CSL Behring Revenue, Growth & Competitor Profile

DBA CSL BEHRING LLC

Company Profile & Annual Report for CSL Behring

Access the complete profile.

CSL Behring Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	1020 First Avenue P.o Box 61501 King Of Prussia, PA 19406

Note: Revenues for privately held companies are statistical evaluations.


CSL Behring's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • CSL Behring's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • CSL Behring is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

CSL Behring Annual Revenue and Growth Rate

CSL Behring	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: CSL Behring's revenues are gauged from an analysis of company filings.

CSL Behring's Income Statement (based on Industry Averages)

CSL Behring P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that CSL Behring is developing and marketing. CSL Behring's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
NEUPATHS Educational services, namely, providing presentations and non-downloadable electronic manuals in the field of health and treatment; Publication of journals, periodicals, articles, and other printed matter of the results of clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis	06/14/2023
NEWPATHS Educational services, namely, providing presentations and non-downloadable electronic manuals in the field of health and treatment; Publication of journals, periodicals, articles, and other printed matter of the results of clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis	06/14/2023
DO THE AMAZING, HELP SAVE LIVES Promoting awareness of life saving blood plasma donation; Promoting awareness of blood diseases, illnesses and conditions; Promoting awareness of vaccines and related illnesses; Promoting the donation of blood plasma by means of arranging and conducting incentive reward and blood plasma donor loyalty programs; Business administration of an incentive reward and blood plasma donor loyalty program to promote blood plasma collection services and collection of blood plasma; Promoting public awareness of blood disorders, treatment and impact on patients	05/03/2023

See all trademarks and details in the Full Report.

Market Share of CSL Behring's Largest Competitors

A competitive analysis shows these companies are in the same general field as CSL Behring, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to CSL Behring. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CSL BEHRING	King Of Prussia, PA	100
CSLB HOLDINGS	King Of Prussia, PA	99
WUXI BIOLOGICS USA	King Of Prussia, PA	2
COLORCON	West Point, PA	2
HARMONY BIOSCIENCES	Plymouth Meeting, PA	1
IMMUNOCORE COMMERCIAL	Conshohocken, PA	0

Future Competition: CSL Behring's Fastest Growing Competitors

These companies are in the same general field as CSL Behring and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)